COVALAB Revenue and Competitors

Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the scientists at CovalAb have more than 30 years of experience in the chemical modification of antigens and antibodies destined for diagnosis and therapy. A list, by no means complete of some of their achievements: - In biomedicine, includes the production of: antibodies directed against new tumour markers, antibodies as gene vectors in cancerology, antibodies reacting specifically with cerebral protein aggregates in neurology, diagnostic kits for detecting patients with autoimmune disease such as rheumatoid arthritis and celiac disease. - In agro-food, the development of complete diagnostic kits including the antibodies and the chemically modified immunogens for the detection of mycotoxins, phycotoxins, pesticides and polyaromatic hydrocarbons. Our mission is to give to researchers every day high quality antibodies and powerful tools to accelerate your research and move on to discovery. We help our clients to face new challenges in biology and to improve life thanks to translational research, personalized medicine, stem cell therapy and food safety.